v' Quantitation of the concentration of immunoproteins in serum, and cystic fluids from six patients (three with cerebral astrocytoma and three with cerebellar hemangioblastoma) has been determined. The values for total protein, albumin, immunoproteins IgG, IgA, and IgM, and C8c (complement) in cyst fluid more closely correspond to serum than to Cerebrospinal fluid values. Values for cyst fluid, cerebrospinal fluid, and serum were determined using albumin ratios in order to compare relative differences between fluids from these three compartments. Our data suggest that: 1) the major protein content of brain tumor cyst fluid is consequential to a transudative process from serum, and 2) that immunoglobulins IgG and IgA are present in higher concentrations in human brain tumor cyst fluids in comparison to IgM concentrations. These studies further question the concept of the brain as an "immunologically privileged site," and may be of direct relevance to the investigation of the use of immunotherapeutic modalities as an adjunct after surgical tumor removal. KEY WORDS 9 astrocytoma 9 hemangioblastoma 9 cysts 9 immunology 9 immunoglobulins 9 blood-brain barrier T
T HE brain has been considered by some investigators to be an "immunologically privileged site. ''s,14 This statement is based on the premise that the lack of a lymphatic system in the central nervous system and the presence of a selectively permeable blood-brain barrier leaves the brain incapable of eliciting or supporting an immune response. According to this hypothesis tumor-killer cells such as sensitized lymphocytes cannot gain access to the brain through an intact blood-brain barrier, nor can antibody proteins with large molecular weight that are directed against tumor cells leave the blood vessels and enter brain neoplasms. However, in 1965, Scheinberg, et al.) 7 reported the brain to be only "relatively" privileged from an immunological standpoint, since mice previously cured of their subcutaneous tumors by irradiation could reject subsequent brain-tumor inoculations. In addition, mice vaccinated with subcutaneous tumor before intracranial tumor implantation had a significant increase in median survival time when compared to unvaccinated controls.
Such evidence suggests immune mechanism in tumor rejection and also gives credence to the premise that the brain can support an immunological response. Mahaley, et al., is demonstrated antiglioma antibody, or immunoproteins, in brain tumors of patients. They used fresh glioma obtained from the operating room, homogenized the tumor, and then froze portions for later use as antigen in rabbits in order to generate antiglioma anti- body which was tagged with a radioactive iodine isotope. When the patients returned to the hospital because of tumor recurrence, the operation was preceded several days by an ipsilateral internal carotid artery infusion of radioactive antiglioma antibody before brain scanning. The labeled antibodies were found predominantly in areas of recurrent glioma on 18 of 23 brain scans. Furthermore, antiglioma antibody was located within tumor cells and their neovascular structures on radioautographs of histological sections of tumor tissue obtained from the second operation. These antibodies, however, were also localized to a lesser extent within normal brain, indicating a lack of "specificity" for the brain-tumor cells.
Although this work showed that serum immunoproteins could enter solid brain tumors in man, we believed that additional information about the entry of serum immunoproteins into brain tumors might be obtained by analyzing brain tumor cyst fluid. Therefore, in this study cyst fluid from human brain tumors was analyzed 1) to identify the immunochemical content of cysts occurring within brain tumors, 2) to determine whether large antibody proteins such as immunoglobulins occur within such cysts, and 3) to seek clues as to the source of cyst fluid within brain tumors.
Clinical Material and Methods
The clinical data on the six patients in this study is given in Table 1 . None of the patients had any known immunological disorder, nor had received immunosuppressant drugs.
At surgery cyst fluid from brain tumors was collected from three patients with cerebral astrocytomas and three patients with cerebellar hemangioblastomas. The samples were placed in sterile containers, centrifuged at 1200 rpm for 10 minutes, then stored at -70 ~ C. No erythrocyte pellets were seen after sample centrifugation. Pre-or postoperatively the patients' sera and cerebrospinal fluid (CSF) were collected and processed in a manner identical to the cyst fluids. No patient received transfused blood before sample collection. All samples were analyzed for total protein content using the Folin assay g and ultraviolet spectrophotometry at a wave length of 260 to 280 ~t. Quantitative measurements of IgA, IgM, IgG, total albumin, and C3c (B1A globulin) ("complement"), were evaluated by radial immunodiffusion* methods. 6 All readings were performed twice. The normal serum values for adult subjects in this laboratory are IgG 12 + 2.45 mg/ml, IgA 2 + 0.7 mg/ml, and IgM 1.0 + 0.45 mg/ml. Normal serum C3c concentration is 1.42 + 0.40 mg/ml. 15 The normal CSF values using immunodiffusion plates reported by Glasner 7 are IgG 0.015 mg/ml, IgA 0.0019 mg/ml, and IgM 0.0 mg/ml. In order to exclude possible blood contamination in cyst fluid at the time of operation, results were *Quantitative immunodiffusion plates obtained from Meloy Laboratories, Springfield, Virginia, and Behring Diagnostics, Somerville, New Jersey. analyzed by comparing serum and cyst albumin ratios. Albumin was chosen as a reference standard 1~ because of its smaller molecular weight and size as compared to immunoproteins. The lower limits of sensitivity of the quantitative immunoglobulin methods used in our study is 0.15 mg/ml with a maximum deviation of 9%. Table 2 lists the values for total protein and albumin of cystic fluid, CSF, and serum samples derived from three patients with cerebral astrocytoma and three patients with cerebellar hemangioblastoma. Values for total protein from the cyst fluids are high and range from 17 to 44 times that of CSF values; in addition, cyst fluid protein and albumin quantities are closer to those of serum than to those of CSF.
Results
Immunoglobulins are found within cyst fluids of astrocytomas and hemangioblastomas. Tables 3-6 show comparisons for IgG, IgA, IgM, and C8c (B1A globulin) ("complement"), respectively. We found IgG, IgA, and Csc (B1A globulin) present in high quantities in all cystic brain tumors studied. However, IgM values in cyst fluid are low to absent; in addition, the IgM to albumin ratios in cyst fluid are low as compared to serum ratios.
Discussion
In 1939, Bucy and Gustafson' emphasized the xanthochromic nature of cystic fluid contained in certain astrocytomas and noted its high protein content.
Other investigators 5'~8-2~ have also demonstrated that high protein concentration occurs within cyst fluids of human brain tumors. Cyst formation occurs frequently within astrocytomas and hemangioblastomas; is in fact, fibrillary and juvenile cerebellar astrocytomas have been known to harbor cysts of massive size? ,~e Russell and Rubinstein le have described multiple microcystic areas in astrocytoma and have attributed the cyst formation to an interference with tumor blood supply and tumor cell necrosis. Several glycolytic and lysosomal enzymes, most likely originating from tumor cells, have been shown to be present in brain tumor cyst fluid. 2,8a~ Since tumor cells are not known to contain immunoproteins, however, it is unlikely that their origin is from necrotic tumor cells. Long TM demonstrated that in human malignant brain tumors capillary endothelial junctions can develop abnormal gaps of 500 to 1000 A, and that some brain tumor capillaries lacked normal glial sheaths, thus leading to direct continuity of the basement membranes with the extracellular space. There may be a similar pathological anatomical substrate for capillary junctions within brain tumor cysts. If so, significant quantities of immunoproteins could cross these abnormal capillary walls and, together with other smaller proteins such as albumin, could permeate and/or have a dynamic role in brain-tumor cyst formation.
Another possibility is that proteins could accumulate as a result of hemorrhage. The fact that the IgM concentrations in cysts (corrected or uncorrected for albumin concentration) were less than those in serum suggests that its presence is not a direct result of hemorrhage, under which conditions it would be present in concentrations similar to serum. Since this immunoprotein has the highest molecular weight of the immunoproteins (approximately 900,000 daltons), its lower concentration could be more 'readily explained by a restricted entry into the cyst because of its large size which would severely impair its diffusion properties. Tables 2 and 3 show that cyst albumin values for Cases 2 and 6 and cyst IgG values for Case 5 are higher than corresponding serum values. A higher concentration of these proteins could occur as the lower molecular weight molecules escape from the fluid at a faster rate than the larger immunoproteins, thus suggesting a concentration mechanism. However, the reformation of cyst fluid after multiple aspiration found in clinical situations would suggest that cyst formation is a dynamic process and not one of stagnation.
The origin of cyst fluid as a secretory product of tumor cells is not likely since astrocytomas and hemangioblastomas have never been reported to secrete immunoglobulins or to contain significant numbers of plasma cells. Loculation of CSF is not a likely source for cyst formation because of the high protein content in cyst fluid. Furthermore, the lack of communication of these cysts with CSF would make this possibility unlikely.
Further studies of human brain tumor cyst fluid are I~eing performed in order to characterize the antibody role of these immunoproteins and to better delineate the biochemical properties necessary for plasma protein permeation into brain-tumor cysts.
Summary
The results of our investigation demonstrate the presence of immunoproteins IgG, IgM, IgA, and complement C3c within cysts of cerebral astrocytomas and cerebellar hemangioblastomas. Our immunochemical studies of cyst fluid using brain tumors from six patients provide evidence that immunoproteins can enter brain tumors.
Quantitative studies of protein, albumin, complement (Cat), and immunoglobulins (IgG, IgA, and IgM) for six cyst fluids from patients harboring brain-tumor cysts have been compared with autologous CSF and serum. The quantitative values for total protein, albumin, complement, and three immunoglobulins all more closely parallel serum than CSF, suggesting that the major protein content of the brain tumor cyst fluid is consequential to a transudative process from serum. Immunoglobulins IgG and IgA were present in higher concentrations in human tumor cyst fluids in comparison to IgM concentrations. These studies further question the concept of the brain as an "immunologically privileged site."
